Marshall Wace North America’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$459K Buy
+92,132
New +$530K ﹤0.01% 1148
2020
Q3
Sell
-39,807
Closed -$198K 1415
2020
Q2
$198K Buy
+39,807
New +$135K ﹤0.01% 1073
2019
Q2
Sell
-2,448
Closed -$13K 1508
2019
Q1
$13K Sell
2,448
-3,969
-62% -$27.5K ﹤0.01% 1437
2018
Q4
$42K Buy
+6,417
New +$71.9K ﹤0.01% 1299

Other funds holding PGEN

Marshall Wace North America's PGEN Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Precigen (PGEN) in Q3 2021: 92,132 shares worth $459K. The stake represents ﹤0.01% of the portfolio and ranks #1148 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in PGEN as recently as Q2 2020.

Marshall Wace North America first reported a position in PGEN in Q4 2018 and has held it in 4 quarters since. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

  • Marshall Wace North America held 92,132 shares of Precigen worth $459K as of Q3 2021.
  • Precigen was a new Marshall Wace North America position in Q3 2021.
  • Precigen made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1148 holding.
  • Marshall Wace North America first reported a position in Precigen in Q4 2018 and has held it in 4 quarters since.
  • 172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.